EVBO publication highlights

March 2026

Deletion of Mfn2 in endothelial cells triggers a mitohormetic response that improves systemic metabolism and healthspan in mice

https://www.cell.com/cell-metabolism/fulltext/S1550-4131(26)00012-4

In this study Iñigo Chivite and collaborators demonstrate that loss of endothelial Mfn2 induces a mitohormetic response that reprograms mitochondrial function and cellular metabolism. It shows that this adaptive signalling improves systemic glucose homeostasis and activates protective stress pathways, highlighting an active role for the endothelium in whole-body metabolic regulation. Finally, the study shows that targeting endothelial mitochondrial dynamics could represent a promising therapeutic strategy for metabolic diseases such as diabetes and obesity.

February 2026

Transcriptomics- and 3D imaging–based characterization of the lymphatic vasculature in human skin.

https://rupress.org/jem/article/223/1/e20242353/278441/Transcriptomics-and-3D-imaging-based

This study combines single-cell transcriptomics with 3D imaging to build the most detailed map to date of the human skin lymphatic vasculature. Aline Bauer and colleagues uncover previously unrecognized lymphatic endothelial cell subtypes, including specialized valve and mechanosensitive populations, and reveal important differences between human and mouse lymphatics. The work provides a new reference atlas for understanding lymphatic function in health and disease.